LOTTE BIOLOGICS located in East Syracuse, NY is seeking an Associate Director, Analytical Sciences & Technology to join our team who entered the biologics Contract Development Manufacturing Organization (CDMO) business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, on January 1, 2023!
The Associate Director, Analytical Science and Technology is responsible for leading a team of analytical scientists to provide lifecycle management of analytical testing methods. The candidate will be responsible for executing the overall scientific, technical, and operational efforts across the method lifecycle. The candidate will oversee activities including, but not limited to, method development, method transfer, phase appropriate method qualification/validation, non-GMP testing, non-GMP stability, reference standard qualification, and comparability for biologics and other modalities to support clinical and/or commercial GMP manufacturing. The candidate will also provide expertise and guidance to support laboratory investigations and troubleshooting for QC and operational issues, as applicable.
This is a leadership position responsible for the strategic planning and growth of the Analytical Development and Lifecycle functions. The role will also be responsible for leading a team of subject matter experts to execute the overall scientific, technical, and operational efforts. The candidate will communicate and execute the analytical strategy, with routine interaction with clients, and will also deliver analytical methods needed to meet project milestones and new product introductions while maintaining associated regulatory and ICH requirements. The candidate will also lead cross-functional efforts to develop analytical CMC strategies, while providing tactical direction for the development and execution of the analytical project plan. The candidate will work in a fast-paced environment, manage priorities, and maintain timelines for multiple projects.
This position requires up to 10% of domestic and/or international travel.
East Syracuse, NY
LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. LOTTE BIOLOGICS entered the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, as of January 1, 2023!
The newly established organization aims to become a Global Top 10 CDMO company in the biopharmaceutical industry. With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea. LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT. LOTTE has 30+ global locations across the US, Europe, and Asia.
An Equal Opportunity Employer
We do not discriminate based on race, color, religion, national origin, sex, age, disability, genetic information, or any other status protected by law or regulation. It is our intention that all qualified applicants are given equal opportunity and that selection decisions be based on job-related factors.
Software Powered by iCIMS